These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8311484)

  • 1. [Molecular biological analyses of mucin core proteins and their clinical application].
    Hinoda Y; Imai K
    Gan To Kagaku Ryoho; 1994 Feb; 21(2):150-6. PubMed ID: 8311484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [New mucin core protein genes and their clinical application].
    Imai K
    Hokkaido Igaku Zasshi; 1996 Mar; 71(2):139-43. PubMed ID: 8641670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Humoral immunity against a tandem repeat epitope of human mucin MUC-1 in sera from breast, pancreatic, and colon cancer patients.
    Kotera Y; Fontenot JD; Pecher G; Metzgar RS; Finn OJ
    Cancer Res; 1994 Jun; 54(11):2856-60. PubMed ID: 7514493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T cells recognize PD(N/T)R motif common in a variable number of tandem repeat and degenerate repeat sequences of MUC1.
    Pisarev VM; Kinarsky L; Caffrey T; Hanisch FG; Sanderson S; Hollingsworth MA; Sherman S
    Int Immunopharmacol; 2005 Feb; 5(2):315-30. PubMed ID: 15652762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biophysical characterization of one-, two-, and three-tandem repeats of human mucin (muc-1) protein core.
    Fontenot JD; Tjandra N; Bu D; Ho C; Montelaro RC; Finn OJ
    Cancer Res; 1993 Nov; 53(22):5386-94. PubMed ID: 8221676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human colon adenocarcinomas express a MUC1-associated novel carbohydrate epitope on core mucin glycans defined by a monoclonal antibody (A10) raised against murine Ehrlich tumor cells.
    Medina M; Vélez D; Asenjo JA; Egea G; Real FX; Gil J; Subiza JL
    Cancer Res; 1999 Mar; 59(5):1061-70. PubMed ID: 10070964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Augmenting the immunogenicity of synthetic MUC1 peptide vaccines in mice.
    Zhang S; Graeber LA; Helling F; Ragupathi G; Adluri S; Lloyd KO; Livingston PO
    Cancer Res; 1996 Jul; 56(14):3315-9. PubMed ID: 8764127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human single-chain Fv antibodies to MUC1 core peptide selected from phage display libraries recognize unique epitopes and predominantly bind adenocarcinoma.
    Henderikx P; Kandilogiannaki M; Petrarca C; von Mensdorff-Pouilly S; Hilgers JH; Krambovitis E; Arends JW; Hoogenboom HR
    Cancer Res; 1998 Oct; 58(19):4324-32. PubMed ID: 9766660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a novel cancer-specific immunodominant glycopeptide epitope in the MUC1 tandem repeat.
    Tarp MA; Sørensen AL; Mandel U; Paulsen H; Burchell J; Taylor-Papadimitriou J; Clausen H
    Glycobiology; 2007 Feb; 17(2):197-209. PubMed ID: 17050588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccinia virus MUC1 immunization of mice: immune response and protection against the growth of murine tumors bearing the MUC1 antigen.
    Acres RB; Hareuveni M; Balloul JM; Kieny MP
    J Immunother Emphasis Tumor Immunol; 1993 Aug; 14(2):136-43. PubMed ID: 8280702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MUC1 synthetic peptide inhibition of intercellular adhesion molecule-1 and MUC1 binding requires six tandem repeats.
    Kam JL; Regimbald LH; Hilgers JH; Hoffman P; Krantz MJ; Longenecker BM; Hugh JC
    Cancer Res; 1998 Dec; 58(23):5577-81. PubMed ID: 9850097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of polymorphism in MUC1 tandem repeats in cancer cells is related to breast cancer progression in Japanese women.
    Kawaguchi T; Takazawa H; Imai S; Morimoto J; Watanabe T
    Breast Cancer Res Treat; 2005 Aug; 92(3):223-30. PubMed ID: 16155793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-specific cytotoxic T cell clones from patients with breast and pancreatic adenocarcinoma recognize EBV-immortalized B cells transfected with polymorphic epithelial mucin complementary DNA.
    Jerome KR; Domenech N; Finn OJ
    J Immunol; 1993 Aug; 151(3):1654-62. PubMed ID: 8393050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epitope mapping of antigenic MUC1 peptides to breast cancer antibody fragment B27.29: a heteronuclear NMR study.
    Grinstead JS; Schuman JT; Campbell AP
    Biochemistry; 2003 Dec; 42(48):14293-305. PubMed ID: 14640698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody and T cell responses of patients with adenocarcinoma immunized with mannan-MUC1 fusion protein.
    Karanikas V; Hwang LA; Pearson J; Ong CS; Apostolopoulos V; Vaughan H; Xing PX; Jamieson G; Pietersz G; Tait B; Broadbent R; Thynne G; McKenzie IF
    J Clin Invest; 1997 Dec; 100(11):2783-92. PubMed ID: 9389743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reactivity of anti-human milk fat globule antibodies with synthetic peptides.
    Xing PX; Tjandra JJ; Reynolds K; McLaughlin PJ; Purcell DF; McKenzie IF
    J Immunol; 1989 May; 142(10):3503-9. PubMed ID: 2715633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of a circulating antibody against a peptide epitope on a mucin core protein, MUC1, in ulcerative colitis.
    Hinoda Y; Nakagawa N; Nakamura H; Makiguchi Y; Itoh F; Adachi M; Yabana T; Imai K; Yachi A
    Immunol Lett; 1993 Feb; 35(2):163-8. PubMed ID: 7685318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adoptive immunotherapy for pancreatic cancer: cytotoxic T lymphocytes stimulated by the MUC1-expressing human pancreatic cancer cell line YPK-1.
    Kawaoka T; Oka M; Takashima M; Ueno T; Yamamoto K; Yahara N; Yoshino S; Hazama S
    Oncol Rep; 2008 Jul; 20(1):155-63. PubMed ID: 18575732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue-specific expression of a human polymorphic epithelial mucin (MUC1) in transgenic mice.
    Peat N; Gendler SJ; Lalani N; Duhig T; Taylor-Papadimitriou J
    Cancer Res; 1992 Apr; 52(7):1954-60. PubMed ID: 1372533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunization of chimpanzees with tumor antigen MUC1 mucin tandem repeat peptide elicits both helper and cytotoxic T-cell responses.
    Barratt-Boyes SM; Vlad A; Finn OJ
    Clin Cancer Res; 1999 Jul; 5(7):1918-24. PubMed ID: 10430099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.